Rabobank

Rabo Investments operates under the Rabobank Group's wholesale banking division, with the Managing Board — chaired by Stefaan Decraene — setting strategic direction. Day-to-day investment committee decisions for the Rabo Food & Agri Innovation Fund and direct growth-equity positions are delegated to a dedicated investment team in Utrecht. The bank does not publicly disclose the names of individual IC members.

Rabobank sources early-stage and growth-equity opportunities primarily through its global Agri lending relationships, which span 37 countries and reach thousands of farm operators, food processors, and equipment suppliers. Its in-house RaboResearch Food & Agribusiness division, which employs over 80 analysts, provides proprietary supply-chain intelligence that surfaces companies and technologies before they reach broad auction processes. The bank also maintains co-investment relationships with specialist venture managers in Europe, Israel, and North America.

Rabobank does both. The Rabo Food & Agri Innovation Fund makes venture-stage direct equity investments and also commits as a limited partner to third-party venture funds operating in food-tech and ag-tech. Additionally, the corporate private-equity arm selectively takes minority stakes in growth-equity rounds alongside external sponsors. Debt capital is placed through Rabo AgriFinance in the US and Rabobank's global structured-finance desks.

Rabo Investments focuses on Series A through growth-equity stages for direct equity, with check sizes typically ranging from €2 million to €20 million in venture rounds. Its fund commitments concentrate on early-stage seed and Series A managers. The bank avoids pre-revenue biotech and deep-tech hardware with science risk, preferring companies that have a demonstrated agronomic or operational proof-of-concept and a clear path to serving the bank's existing client base.

Rabobank does not invest in defense, fossil-fuel extraction, or consumer-facing brands outside its food-and-ag mandate. It also avoids single-use plastics manufacturing and animal agriculture models inconsistent with its published biodiversity and climate targets. Within Food & Agri, the bank will invest in alternative proteins and precision fermentation, but it has publicly excluded live-animal export businesses and any operation linked to deforestation-risk commodities.